DK3340796T3 - Sonder til afbildning af huntingtin-protein - Google Patents
Sonder til afbildning af huntingtin-protein Download PDFInfo
- Publication number
- DK3340796T3 DK3340796T3 DK16842715.1T DK16842715T DK3340796T3 DK 3340796 T3 DK3340796 T3 DK 3340796T3 DK 16842715 T DK16842715 T DK 16842715T DK 3340796 T3 DK3340796 T3 DK 3340796T3
- Authority
- DK
- Denmark
- Prior art keywords
- species
- huntingtin protein
- imaging
- imaging huntingtin
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562211118P | 2015-08-28 | 2015-08-28 | |
| PCT/US2016/049112 WO2017040336A1 (en) | 2015-08-28 | 2016-08-26 | Probes for imaging huntingtin protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3340796T3 true DK3340796T3 (da) | 2021-07-26 |
Family
ID=58103449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16842715.1T DK3340796T3 (da) | 2015-08-28 | 2016-08-26 | Sonder til afbildning af huntingtin-protein |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US10137211B2 (da) |
| EP (1) | EP3340796B1 (da) |
| JP (1) | JP6944929B2 (da) |
| CN (1) | CN108135172B (da) |
| AU (1) | AU2016315648B2 (da) |
| BR (1) | BR112018003331B1 (da) |
| CA (1) | CA2995847A1 (da) |
| DK (1) | DK3340796T3 (da) |
| ES (1) | ES2885053T3 (da) |
| HR (1) | HRP20211156T1 (da) |
| HU (1) | HUE056509T2 (da) |
| IL (1) | IL257537B (da) |
| MX (1) | MX2018002338A (da) |
| PL (1) | PL3340796T4 (da) |
| PT (1) | PT3340796T (da) |
| RU (1) | RU2721419C2 (da) |
| SI (1) | SI3340796T1 (da) |
| WO (1) | WO2017040336A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3186241T3 (pl) | 2014-08-29 | 2021-05-17 | Chdi Foundation, Inc. | Sondy do obrazowania białka huntingtyny |
| SG11201701592SA (en) | 2014-08-29 | 2017-03-30 | Chdi Foundation Inc | Probes for imaging huntingtin protein |
| ES2818107T3 (es) | 2014-08-29 | 2021-04-09 | Chdi Foundation Inc | Sondas para obtener imágenes de la proteína huntingtina |
| EA035646B1 (ru) | 2014-08-29 | 2020-07-21 | Сиэйчдиай Фаундэйшн, Инк. | Зонды для визуализации белка хантингтина |
| WO2017040336A1 (en) | 2015-08-28 | 2017-03-09 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
| WO2019157272A1 (en) * | 2018-02-08 | 2019-08-15 | Phraxis Inc. | One piece anastomotic connector |
| WO2020176424A1 (en) | 2019-02-25 | 2020-09-03 | Chdi Foundation, Inc. | Compounds for targeting mutant huntingtin protein and uses thereof |
| US11918662B2 (en) | 2020-06-11 | 2024-03-05 | Chdi Foundation, Inc. | Heterocyclic compounds and imaging agents for imaging huntingtin protein |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE172975T1 (de) | 1992-05-19 | 1998-11-15 | Adir | Benzimidezolderivate mit antidiabetischer und anti-plättchenklumpungswirkung |
| JP2000351782A (ja) * | 1999-04-06 | 2000-12-19 | Yamanouchi Pharmaceut Co Ltd | メタボトロピックグルタメート受容体作用薬及び新規チアゾロベンゾイミダゾール誘導体 |
| AU2241400A (en) * | 1999-04-06 | 2000-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | Novel thiazolobenzoimidazole derivative |
| UY27003A1 (es) * | 2000-11-06 | 2002-07-31 | Schering Ag | Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer |
| US20050148605A1 (en) * | 2003-11-13 | 2005-07-07 | Ambit Biosciences Corporation | Amide derivatives as ABL modulators |
| TW201018678A (en) * | 2006-01-27 | 2010-05-16 | Astrazeneca Ab | Novel heteroaryl substituted benzothiazoles |
| FR2919610B1 (fr) | 2007-08-02 | 2009-10-16 | Sanofi Aventis Sa | Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique |
| EP2323697A2 (en) * | 2008-07-24 | 2011-05-25 | Siemens Medical Solutions USA, Inc. | Imaging agents useful for identifying ad pathology |
| EP2218464A1 (en) * | 2009-02-11 | 2010-08-18 | Technische Universität München | Compounds for non-invasive measurement of aggregates of amyloid peptides |
| EP2411057B1 (en) * | 2009-03-23 | 2020-05-06 | Eli Lilly and Company | Imaging agents for detecting neurological disorders |
| WO2014011906A2 (en) | 2012-07-11 | 2014-01-16 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
| US9902702B2 (en) * | 2014-07-15 | 2018-02-27 | Bristol-Myers Squibb Company | Spirocycloheptanes as inhibitors of rock |
| EA035646B1 (ru) | 2014-08-29 | 2020-07-21 | Сиэйчдиай Фаундэйшн, Инк. | Зонды для визуализации белка хантингтина |
| ES2818107T3 (es) | 2014-08-29 | 2021-04-09 | Chdi Foundation Inc | Sondas para obtener imágenes de la proteína huntingtina |
| SG11201701592SA (en) | 2014-08-29 | 2017-03-30 | Chdi Foundation Inc | Probes for imaging huntingtin protein |
| PL3186241T3 (pl) | 2014-08-29 | 2021-05-17 | Chdi Foundation, Inc. | Sondy do obrazowania białka huntingtyny |
| WO2017040336A1 (en) | 2015-08-28 | 2017-03-09 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
-
2016
- 2016-08-26 WO PCT/US2016/049112 patent/WO2017040336A1/en active Application Filing
- 2016-08-26 CA CA2995847A patent/CA2995847A1/en active Pending
- 2016-08-26 BR BR112018003331-6A patent/BR112018003331B1/pt active IP Right Grant
- 2016-08-26 SI SI201631285T patent/SI3340796T1/sl unknown
- 2016-08-26 DK DK16842715.1T patent/DK3340796T3/da active
- 2016-08-26 HU HUE16842715A patent/HUE056509T2/hu unknown
- 2016-08-26 CN CN201680059497.1A patent/CN108135172B/zh active Active
- 2016-08-26 RU RU2018110055A patent/RU2721419C2/ru active
- 2016-08-26 ES ES16842715T patent/ES2885053T3/es active Active
- 2016-08-26 HR HRP20211156TT patent/HRP20211156T1/hr unknown
- 2016-08-26 EP EP16842715.1A patent/EP3340796B1/en active Active
- 2016-08-26 PT PT168427151T patent/PT3340796T/pt unknown
- 2016-08-26 US US15/249,223 patent/US10137211B2/en active Active
- 2016-08-26 PL PL16842715T patent/PL3340796T4/pl unknown
- 2016-08-26 AU AU2016315648A patent/AU2016315648B2/en active Active
- 2016-08-26 JP JP2018510377A patent/JP6944929B2/ja active Active
- 2016-08-26 MX MX2018002338A patent/MX2018002338A/es unknown
-
2018
- 2018-02-14 IL IL257537A patent/IL257537B/en active IP Right Grant
- 2018-10-26 US US16/172,425 patent/US10765764B2/en active Active
-
2020
- 2020-08-06 US US16/987,277 patent/US11344637B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190167821A1 (en) | 2019-06-06 |
| IL257537A (en) | 2018-04-30 |
| US10137211B2 (en) | 2018-11-27 |
| EP3340796B1 (en) | 2021-04-21 |
| CA2995847A1 (en) | 2017-03-09 |
| EP3340796A1 (en) | 2018-07-04 |
| PL3340796T3 (pl) | 2022-02-21 |
| RU2018110055A (ru) | 2019-09-30 |
| RU2018110055A3 (da) | 2019-10-28 |
| JP2018531897A (ja) | 2018-11-01 |
| US20210060187A1 (en) | 2021-03-04 |
| CN108135172A (zh) | 2018-06-08 |
| MX2018002338A (es) | 2018-07-06 |
| US20170056535A1 (en) | 2017-03-02 |
| HRP20211156T1 (hr) | 2021-12-24 |
| US11344637B2 (en) | 2022-05-31 |
| ES2885053T3 (es) | 2021-12-13 |
| RU2721419C2 (ru) | 2020-05-19 |
| AU2016315648A1 (en) | 2018-03-29 |
| HUE056509T2 (hu) | 2022-02-28 |
| PL3340796T4 (pl) | 2022-02-21 |
| EP3340796A4 (en) | 2019-05-15 |
| SI3340796T1 (sl) | 2022-02-28 |
| US10765764B2 (en) | 2020-09-08 |
| JP6944929B2 (ja) | 2021-10-06 |
| BR112018003331B1 (pt) | 2022-05-10 |
| IL257537B (en) | 2020-08-31 |
| CN108135172B (zh) | 2021-03-30 |
| BR112018003331A2 (pt) | 2018-11-06 |
| AU2016315648B2 (en) | 2021-04-01 |
| PT3340796T (pt) | 2021-07-28 |
| WO2017040336A1 (en) | 2017-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285366A (en) | Multi-specific antigen-binding proteins | |
| DK3538864T3 (da) | Mikrotom | |
| DK3292137T3 (da) | Proteiner specifikke for cd137 | |
| DK3344654T3 (da) | Anti-lag-3-antistoffer | |
| DK3197453T3 (da) | Kimært protein | |
| DK3316703T3 (da) | Fremgangsmåde til forbedring af dyrs ydeevne | |
| DK3497207T3 (da) | Fremgangsmåder til påvisning af aav | |
| DK3294700T3 (da) | Fremgangsmåde til fremstilling af limonen-4-ol | |
| DK3286311T3 (da) | Fremgangsmåde til behandling af maligniteter | |
| DK3072835T3 (da) | Fremgangsmåde til fremføring | |
| DK3186233T3 (da) | Prober til billeddannelse af huntingtin-protein | |
| DK3384274T3 (da) | Fremgangsmåder til prøvekarakterisering | |
| DK3340796T3 (da) | Sonder til afbildning af huntingtin-protein | |
| DK3350218T3 (da) | Polyomavirus-neutraliserende antistoffer | |
| DK3344805T3 (da) | Fremgangsmåde til udvælgelse af aptamerer til ubundne mål | |
| DK3314010T3 (da) | Fremgangsmåde til detektering af kromosomaberrationer | |
| DK3393468T3 (da) | Fremgangsmåder til behandling af en immundefektsygdom | |
| DK3250593T3 (da) | Anti-transthyretin-antistoffer | |
| MA42692A (fr) | Compositions biopharmaceutiques | |
| DK3341725T3 (da) | Fremgangsmåder til detektering af phosphoryleret alpha-synuklein | |
| DK3519094T3 (da) | System til forberedelse af en prøve | |
| DK3529233T3 (da) | Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider | |
| DK3197277T3 (da) | Prober til billeddannelse af huntingtin-protein | |
| DK3728585T3 (da) | Hidtil ukendte fremgangsmåder til fremstilling af oligonukleotider | |
| DK3366832T3 (da) | Indretning til identifikation af stoftype |